Danaher Co. (NYSE:DHR – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty research firms that are currently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $287.05.
Several equities research analysts have commented on DHR shares. KeyCorp boosted their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada decreased their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Raymond James reduced their price target on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Stephens restated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Finally, Barclays cut their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd.
Get Our Latest Stock Analysis on Danaher
Institutional Investors Weigh In On Danaher
Danaher Stock Performance
Shares of Danaher stock opened at $229.81 on Friday. The firm’s 50 day moving average is $236.58 and its two-hundred day moving average is $254.47. The firm has a market capitalization of $165.99 billion, a P/E ratio of 43.86, a P/E/G ratio of 4.33 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher has a 52 week low of $222.53 and a 52 week high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the company posted $2.02 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. Research analysts forecast that Danaher will post 7.5 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- 5 Top Rated Dividend Stocks to Consider
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Profitably Trade Stocks at 52-Week Highs
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What is Forex and How Does it Work?
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.